AI Article Synopsis
- The study explored how well mucoadhesive films can deliver the immune response modifier imiquimod to the oral mucosa without entering the bloodstream.
- The results showed that while the films effectively localized the drug in the buccal tissue, the cream formulation led to unwanted systemic distribution.
- The films had a residence time of up to 4 hours on oral tissue in humans, suggesting their potential for clinical use in treating oral precancerous lesions.
Article Abstract
Objective: To investigate the ability of mucoadhesive films to locally deliver an immune response modifier (imiquimod) to oral mucosa.
Study Design: After determining the residence time of films in hamster cheek pouches, drug-loaded films and commercially available imiquimod cream were tested for localization of drug in mucosal tissue. The residence time of drug-free films at different locations was also tested in humans.
Results: Mucoadhesive films delivered imiquimod to the buccal mucosa with no measureable amounts in blood. In contrast, although the cream formulation resulted in higher tissue levels, it also led to significant systemic distribution of imiquimod. In humans, the films resided on tissue for up to 4 hours, increasing in the order of tongue < cheek < gingiva.
Conclusion: Preclinical findings of localized imiquimod delivery in animals and residence in humans support future investigations of the mucoadhesive system in controlled clinical trials for treating oral precancerous lesions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oooo.2014.08.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!